In this respect, non-invasive molecular imaging by PET offers a very attractive technology platform, which can provide the required information on the global expression profile or function of the target, such as uPAR, without the need for invasive procedures [3] and the risk of missing the target due to tumor heterogeneity. The gene discussed is PLAUR; the disease is neoplasm.